Genomatica

Founded in 2000 and headquartered in San Diego, Genomatica is a pioneer in industrial biotechnology, leveraging metabolic engineering and synthetic biology to create sustainable chemical intermediates. The company has successfully commercialized its first major product, bio-based 1,4-butanediol (BDO), and is expanding its platform to produce plant-based nylon (Nylon-6) and other materials. By partnering with major global brands and chemical manufacturers, Genomatica is scaling its technology to address a multi-trillion dollar market opportunity for sustainable materials, positioning itself as a key enabler of the circular bioeconomy.

Synthetic biology and metabolic engineering platform that designs microorganisms to ferment plant sugars into target chemical building blocks (e.g., BDO, caprolactam).

Genomatica competes with other synthetic biology firms (e.g., Zymergen, Ginkgo Bioworks' spin-outs) and established chemical companies developing bio-based routes. Its first-mover commercial advantage in BDO and strong partnerships with major manufacturers provide a significant competitive edge in scaling.